Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
E
Show more
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of atopic dermatitis, autoimmune diseases and disorders, dermatological diseases and disorders, inflammation and inflammatory diseases and disorders
Class 5 – Pharmaceuticals & supplements
Status timeline
- 4 Aug 2022Application filedNew Application Entered
- 17 May 2023Assigned to an examining attorneyAssigned To Examiner
- 23 May 2023Office action issuedNon-Final Action Written
- 24 May 2023Approved for publicationApproved For Pub - Principal Register
- 27 Jun 2023Published for oppositionPublished For Opposition
- 22 Aug 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 16 Jan 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 16 Jul 2024Statement-of-use extension 2 grantedSou Extension 2 Granted
- 25 Apr 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
- 21 Jul 2025Statement of use filedTeas Statement Of Use Received
- 5 Sep 2025Statement of use acceptedAllowed Principal Register - Sou Accepted
- 30 Sep 2025Registered on the Principal RegisterRegistered-Principal Register
All 36 events
| 2025-09-30 | Registered-Principal Register |
| 2025-09-30 | Notice Of Registration Confirmation Emailed |
| 2025-09-05 | Allowed Principal Register - Sou Accepted |
| 2025-09-05 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2025-08-04 | Statement Of Use Processing Complete |
| 2025-07-21 | Teas Statement Of Use Received |
| 2025-07-21 | Use Amendment Filed |
| 2025-04-25 | Case Assigned To Intent To Use Paralegal |
| 2025-04-25 | Sou Extension 3 Granted |
| 2025-04-25 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-01-27 | Sou Teas Extension Received |
| 2025-01-27 | Sou Extension 3 Filed |
| 2024-07-16 | Sou Teas Extension Received |
| 2024-07-16 | Sou Extension 2 Filed |
| 2024-07-16 | Sou Extension 2 Granted |
| 2024-07-16 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-01-18 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-01-16 | Sou Teas Extension Received |
| 2024-01-16 | Sou Extension 1 Filed |
| 2024-01-16 | Sou Extension 1 Granted |
| 2023-08-22 | Noa Mailed - Sou Required From Applicant |
| 2023-06-27 | Published For Opposition |
| 2023-06-27 | Official Gazette Publication Confirmation E-Mailed |
| 2023-06-07 | Notification Of Notice Of Publication E-Mailed |
| 2023-05-24 | Examiners Amendment -Written |
| 2023-05-24 | Examiners Amendment E-Mailed |
| 2023-05-24 | Notification Of Examiners Amendment E-Mailed |
| 2023-05-24 | Examiner's Amendment Entered |
| 2023-05-24 | Approved For Pub - Principal Register |
| 2023-05-23 | Non-Final Action Written |
| 2023-05-23 | Non-Final Action E-Mailed |
| 2023-05-23 | Notification Of Non-Final Action E-Mailed |
| 2023-05-17 | Assigned To Examiner |
| 2022-08-24 | Notice Of Design Search Code E-Mailed |
| 2022-08-23 | New Application Office Supplied Data Entered |
| 2022-08-04 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of atopic dermatitis, autoimmune diseases and disorders, dermatological diseases and disorders, inflammation and inflammatory diseases and disorders
First use anywhere 30 Sep 2024 · First use in commerce 30 Sep 2024
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 30 Sep 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.